With the deal, the US company extends its market into nine European countries by integrating mobility services
First closing of the new fund of the investment vehicle specialised in early-stage biotech start-ups
The new fund is participated by EU resources and also by investors debuting in venture capital
Click here to read previous Newsletters
Subscribe to the newsletter
yes
en
* I agree that my personal data will be used in accordance with the Privacy and Cookie Policy.
* I authorize the processing of my personal data to be updated on new arrivals and for direct marketing purposes related to the services offered.